The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine

Biological Psychiatry

Volumn 45, Issue 2, 1999, Pages 180-186

  Attar Lévy, Dominique ^a,c   Martinot, Jean Luc ^b,d   Blin, Jérôme ^a   Dao Castellana, Marie Hélène ^a   Crouzel, Christian ^a   Mazoyer, Bernard ^a   Poirier, Marie France ^c   Bourdel, Marie Chantal ^c   Aymard, Nicole ^c   Syrota, André ^a   Féline, André ^d  

^a DIF   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

18F setoperone; Clomipramine; Depression; Positron emission tomography; Serotonin2 receptors

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BRAIN RECEPTOR; BROMAZEPAM; CLOMIPRAMINE; CLORAZEPATE; FLUOXETINE; LORAZEPAM; SEROTONIN 2 RECEPTOR; SETOPERONE; SETOPERONE F 18; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; PYRIMIDINONE DERIVATIVE; SEROTONIN RECEPTOR;

ADULT; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; FEMALE; FRONTAL CORTEX; HUMAN; LONG TERM CARE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME; AGED; BINDING SITE; BRAIN; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SCINTISCANNING;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BINDING SITES; BRAIN; CLOMIPRAMINE; DEPRESSIVE DISORDER; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; PYRIMIDINONES; RECEPTORS, SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033554885     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00007-9     Document Type: Article

References (49)

1. 2 and β-adrenergic receptor binding sites in the human brain of suicide victims. Arch Gen Psychiatry. 47:1990;1038-1047.
2. 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography. J Neurochem. 44:1985;835-844.
3. 2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry. 146:1989;730-736.
4. 2 receptor antagonist. Hartmann A., Hoyer S. Cerebral Blood Flow and Metabolism Measurement. 1985;471-480 Springer-Verlag, Berlin.
5. Baxter L.R., Schwartz J.M., Phelps M.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:1989;243-250.
6. 2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology (Berl). 102:1990;73-75.
7. Blackshear M.A., Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther. 221:1982;303-308.
8. 18F-setoperone studies in humans using positron emission tomography. J Neurochem. 5:1992;2303-2310.
9. 2 receptors in Alzheimer's disease - In vivo assessment with positron emission tomography and 18F-setoperone. Brain. 116:1993;497-510.
10. 18F-labeled setoperone. J Neurochem. 54:1990;1744-1754.
11. Bradford L.D., Tulp M.T., Schipper J. Biochemical effects in rats after acute and long-term treatment with clovoxamine. Arch Int Pharmacodyn. 287:1987;188-202.
12. 18F]-2-deoxyglucose in affective illness. J Affect Disord. 10:1986;137-152.
13. 2 receptor binding sites in depressed suicide victims. Brain Res. 443:1988;272-280.
14. Cowen P.J., Charig E.M., Fraser S., Elliott J.M. Platelet 5HT receptor binding during depressive illness and tricyclic antidepressant treatment. J Affect Disord. 13:1987;45-50.
15. 18F]-setoperone. J Labelled Compounds Radiopharmaceuticals. 25:1988;403-414.
16. Crow T.J., Cross A.J., Cooper S.J., et al. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology. 23:1984;1561-1569.
17. 2 receptors in depression. Psychiatry Res Neuroimaging. 45:1992;227-237.
18. 2 receptors in cerebral cortex. Neuropharmacology. 24:1985;947-952.
19. 1-dopamine receptors studied by PET - A comparison to the equilibrium analysis. J Cereb Blood Flow Metab. 9:1989;696-708.
20. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State" A practical method for grading the cognitive state of the patients for the clinician . J Psychiatr Res. 12:1975;189-198.
21. Green A.R., Johnson P., Mountford J.A., Nimgaonkar V.L. Some anticonvulsant rugs alter monaamine mediated behaviour in mice in ways similar to electroconvulsive shock implications for antidepressant therapy . Br J Pharmacology. 84:1985;337-346.
22. 2 receptors of the human brain postmortem. Brain Res. 519:1990;223-227.
23. 2 antagonists. Drug Dev Res. 8:1986;133-140.
24. Laplane D., Levasseur M., Pillon B., et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions - A neuropsychological, magnetic resonance imaging and positron tomography study. Brain. 112:1989;699-725.
25. 2 receptors in rat brain following chronic receptor blockade. J Recept Res. 7:1987;223-239.
26. 2 antagonists, ritanserin, and setoperone. Gram D., Potter P. Psychopharmacology Series 3 Clinical Pharmacology in Psychiatry . 1987;214-224 Springer-Verlag, Berlin.
27. Linnoila M., Insel T., Kilts C., et al. Plasma steady-state concentrations of hydroxylated metabolites of clomipramine. Clin Pharmacol Ther. 32:1982;208-211.
28. Mann E., Enna S.J. Neurochemical and behavioral correlates of antidepressant drug action. Life Sci. 30:1982;1653-1661.
29. Mann J.J., Stanley M., McBride A., McEwen B.S. Increased serotonin-2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
30. 2 binding sites in human frontal cortex and hippocampus - Selective loss of S-2A sites with age. Brain Res. 311:1984;51-56.
31. Martinot J., Hardy P., Féline A., et al. Left prefrontal glucose hypometabolism in the depressed state - A confirmation. Am J Psychiatry. 147:1990;1313-1317.
32. 2 receptors after stroke - Lateralized changes and relationship to depression. Am J Psychiatry. 145:1988;937-943.
33. McKeith I.G., Marshall E.F., Ferrier I.N., et al. 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord. 13:1987;67-74.
34. Middlemiss D.N., Hibert M., Fozard J.R. Drug acting at central 5-hydroxytryptamine receptors. Bailey D.M. Annual Report in Medicinal Chemistry. vol 21:1986;41-50 Academic Press, San Diego, CA.
35. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:1979;382-389.
36. Owen F., Chambers D.R., Cooper S.J., et al. Serotonergic mechanisms in brains of suicide victims. Brain Res. 362:1986;185-188.
37. Pandey G.N., Pandey S.C., Janicak P.G., et al. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry. 28:1990;215-222.
38. 2) receptors labeled with (3H)-spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther. 215:1980;582-587.
39. 3H] imipramine binding in platelets after chlorimipramine in healthy volunteers - Comparison with maprotiline and amineptine. Biol Psychiatry. 22:1987;287-302.
40. Schoups A.A., De Potter W.P. Species dependence of adaptations at the pre and postsynaptic serotonergic receptors following long-term antidepressant drug treatment. Biochem Pharmacol. 37:1988;4451-4460.
41. Schoups A.A., Dillen L., Claeys M., et al. Characterization of serotonin receptors and lack of effect of antidepressant therapy on monoamine functions in various regions of the rabbit brain. Eur J Clin Pharmacol. 126:1986;259-271.
42. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 29:1983;214-216.
43. Stolz J.F., Marsden C.A., Middlemiss D.N. Effect of chronic antidepressant treatment and subsequent withdrawal on (3H)-5-hydroxytryptamine and (3H)-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology (Berl). 80:1983;150-155.
44. Takahashi R., Tateishi T., Yoshida H., Hironaka I. Effects of chronic treatment with antidepressant drugs on serotonergic receptor binding activity in normal and tetrabenazine depression rat. Langer S.Z., et al. New Vistas in Depression Congress, July 30-31 1981, Nagasaki, Japan. 1982;29-36 Pergamon, Oxford.
45. Traiffort E., Hubert P., Tayeb N., Aymard N. Rapid determination of 5-hydroxytryptamine in whole blood by liquid chromatography with fluorimetric detection. J Chromatogr. 571:1991;231-234.
46. Wagner H.R., Reches A., Yablonskaya E., Fahn S. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex. Fahn S., Marsden D., Van Woert M. Advances in Neurology, vol 43 Myoclonus . 1986;645-651 Raven Press, New York.
47. Wamsley J.K., Byerley W.F., McCabe R.T., et al. Receptor alterations associated with serotonergic agents - An autoradiographic analysis. J Clin Psychiatry. 48:(suppl 3):1987;19-25.
48. Wong D.F., Wagner H.N., Dannals R.F., et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science. 226:1984;1393-1396.
49. 2 receptor changes in major depression. Biol Psychiatry. 27:1990;489-496.